Cargando…

Association of right ventricular dysfunction and pulmonary hypertension with adverse 30-day outcomes in COVID-19 patients

BACKGROUND: Cardiac manifestations in COVID-19 are multifactorial and are associated with increased mortality. The clinical utility and prognostic value of echocardiography in COVID-19 inpatients is not clearly defined. We aim to identify echocardiographic parameters that are associated with 30-day...

Descripción completa

Detalles Bibliográficos
Autores principales: Wats, Karan, Rodriguez, Daniel, Prins, Kurt W., Sadiq, Adnan, Fogel, Joshua, Goldberger, Mark, Moskovits, Manfred, Tootkaboni, Mahsa Pourabdollah, Shani, Jacob, Jacob, Jessen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060770/
https://www.ncbi.nlm.nih.gov/pubmed/33959257
http://dx.doi.org/10.1177/20458940211007040
_version_ 1783681433526599680
author Wats, Karan
Rodriguez, Daniel
Prins, Kurt W.
Sadiq, Adnan
Fogel, Joshua
Goldberger, Mark
Moskovits, Manfred
Tootkaboni, Mahsa Pourabdollah
Shani, Jacob
Jacob, Jessen
author_facet Wats, Karan
Rodriguez, Daniel
Prins, Kurt W.
Sadiq, Adnan
Fogel, Joshua
Goldberger, Mark
Moskovits, Manfred
Tootkaboni, Mahsa Pourabdollah
Shani, Jacob
Jacob, Jessen
author_sort Wats, Karan
collection PubMed
description BACKGROUND: Cardiac manifestations in COVID-19 are multifactorial and are associated with increased mortality. The clinical utility and prognostic value of echocardiography in COVID-19 inpatients is not clearly defined. We aim to identify echocardiographic parameters that are associated with 30-day clinical outcomes secondary to COVID-19 hospitalization. METHODS: This retrospective cohort study was conducted in a large tertiary hospital in New York City during the COVID-19 pandemic. It included 214 adult inpatients with a laboratory-confirmed diagnosis of COVID-19 by reverse transcriptase polymerase chain reaction assay (RT-PCR) for SARS-CoV-2 on nasopharyngeal swab and had a transthoracic echocardiogram performed during the index hospitalization. Primary outcome was 30-day all-cause inpatient mortality. Secondary outcomes were 30-day utilization of mechanical ventilator support, vasopressors, or renal replacement therapy. RESULTS: Mild right ventricular systolic dysfunction (odds ratio (OR): 3.51, 95% confidence interval (CI): 1.63–7.57, p = 0.001), moderate to severe right ventricular systolic dysfunction (OR: 7.30, 95% CI: 2.20–24.25, p = 0.001), pulmonary hypertension (OR: 5.39, 95% CI: 1.96–14.86, p = 0.001), and moderate to severe tricuspid regurgitation (OR: 3.92, 95% CI: 1.71–9.03, p = 0.001) were each associated with increased odds of 30-day all-cause inpatient mortality. Pulmonary hypertension and moderate to severe right ventricular dysfunction were each associated with increased odds of 30-day utilization of mechanical ventilator support and vasopressors. CONCLUSIONS: Right ventricular dysfunction, pulmonary hypertension, and moderate to severe tricuspid regurgitation were associated with increased odds for 30-day inpatient mortality. This study highlights the importance of echocardiography and its clinical utility and prognostic value for evaluating hospitalized COVID-19 patients.
format Online
Article
Text
id pubmed-8060770
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-80607702021-05-05 Association of right ventricular dysfunction and pulmonary hypertension with adverse 30-day outcomes in COVID-19 patients Wats, Karan Rodriguez, Daniel Prins, Kurt W. Sadiq, Adnan Fogel, Joshua Goldberger, Mark Moskovits, Manfred Tootkaboni, Mahsa Pourabdollah Shani, Jacob Jacob, Jessen Pulm Circ Original Research Article BACKGROUND: Cardiac manifestations in COVID-19 are multifactorial and are associated with increased mortality. The clinical utility and prognostic value of echocardiography in COVID-19 inpatients is not clearly defined. We aim to identify echocardiographic parameters that are associated with 30-day clinical outcomes secondary to COVID-19 hospitalization. METHODS: This retrospective cohort study was conducted in a large tertiary hospital in New York City during the COVID-19 pandemic. It included 214 adult inpatients with a laboratory-confirmed diagnosis of COVID-19 by reverse transcriptase polymerase chain reaction assay (RT-PCR) for SARS-CoV-2 on nasopharyngeal swab and had a transthoracic echocardiogram performed during the index hospitalization. Primary outcome was 30-day all-cause inpatient mortality. Secondary outcomes were 30-day utilization of mechanical ventilator support, vasopressors, or renal replacement therapy. RESULTS: Mild right ventricular systolic dysfunction (odds ratio (OR): 3.51, 95% confidence interval (CI): 1.63–7.57, p = 0.001), moderate to severe right ventricular systolic dysfunction (OR: 7.30, 95% CI: 2.20–24.25, p = 0.001), pulmonary hypertension (OR: 5.39, 95% CI: 1.96–14.86, p = 0.001), and moderate to severe tricuspid regurgitation (OR: 3.92, 95% CI: 1.71–9.03, p = 0.001) were each associated with increased odds of 30-day all-cause inpatient mortality. Pulmonary hypertension and moderate to severe right ventricular dysfunction were each associated with increased odds of 30-day utilization of mechanical ventilator support and vasopressors. CONCLUSIONS: Right ventricular dysfunction, pulmonary hypertension, and moderate to severe tricuspid regurgitation were associated with increased odds for 30-day inpatient mortality. This study highlights the importance of echocardiography and its clinical utility and prognostic value for evaluating hospitalized COVID-19 patients. SAGE Publications 2021-04-19 /pmc/articles/PMC8060770/ /pubmed/33959257 http://dx.doi.org/10.1177/20458940211007040 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Article
Wats, Karan
Rodriguez, Daniel
Prins, Kurt W.
Sadiq, Adnan
Fogel, Joshua
Goldberger, Mark
Moskovits, Manfred
Tootkaboni, Mahsa Pourabdollah
Shani, Jacob
Jacob, Jessen
Association of right ventricular dysfunction and pulmonary hypertension with adverse 30-day outcomes in COVID-19 patients
title Association of right ventricular dysfunction and pulmonary hypertension with adverse 30-day outcomes in COVID-19 patients
title_full Association of right ventricular dysfunction and pulmonary hypertension with adverse 30-day outcomes in COVID-19 patients
title_fullStr Association of right ventricular dysfunction and pulmonary hypertension with adverse 30-day outcomes in COVID-19 patients
title_full_unstemmed Association of right ventricular dysfunction and pulmonary hypertension with adverse 30-day outcomes in COVID-19 patients
title_short Association of right ventricular dysfunction and pulmonary hypertension with adverse 30-day outcomes in COVID-19 patients
title_sort association of right ventricular dysfunction and pulmonary hypertension with adverse 30-day outcomes in covid-19 patients
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060770/
https://www.ncbi.nlm.nih.gov/pubmed/33959257
http://dx.doi.org/10.1177/20458940211007040
work_keys_str_mv AT watskaran associationofrightventriculardysfunctionandpulmonaryhypertensionwithadverse30dayoutcomesincovid19patients
AT rodriguezdaniel associationofrightventriculardysfunctionandpulmonaryhypertensionwithadverse30dayoutcomesincovid19patients
AT prinskurtw associationofrightventriculardysfunctionandpulmonaryhypertensionwithadverse30dayoutcomesincovid19patients
AT sadiqadnan associationofrightventriculardysfunctionandpulmonaryhypertensionwithadverse30dayoutcomesincovid19patients
AT fogeljoshua associationofrightventriculardysfunctionandpulmonaryhypertensionwithadverse30dayoutcomesincovid19patients
AT goldbergermark associationofrightventriculardysfunctionandpulmonaryhypertensionwithadverse30dayoutcomesincovid19patients
AT moskovitsmanfred associationofrightventriculardysfunctionandpulmonaryhypertensionwithadverse30dayoutcomesincovid19patients
AT tootkabonimahsapourabdollah associationofrightventriculardysfunctionandpulmonaryhypertensionwithadverse30dayoutcomesincovid19patients
AT shanijacob associationofrightventriculardysfunctionandpulmonaryhypertensionwithadverse30dayoutcomesincovid19patients
AT jacobjessen associationofrightventriculardysfunctionandpulmonaryhypertensionwithadverse30dayoutcomesincovid19patients